• Latest Highlights
  • Archive
  • Systemic Issues
    • Access
    • Cost
    • Health IT
    • Health Reform
    • Learning Organization
    • Quality
  • Industry-Specific Issues
    • Drugs and Medical Devices
    • Health Insurance
    • Providers
    • Public Health
  • Health Data
    • National HCAHPS Response Averages
    • State HCAHPS Response Averages
  • Receive Weekly Updates
 

« Enrollees largely unaware of Medicaid redetermination process

Use of ACA preventive services potentially affected by Braidwood v. Becerra »

Paxlovid becomes 1st approved COVID-19 pill

Categories:

Becker's Hospital Review, Channels, Featured, ROOT

May 25, 2023

by Becker's Hospital Review - Healthcare News

The FDA granted Pfizer's popular COVID-19 antiviral treatment, Paxlovid, full approval on May 25.

Read the full post at Becker's Hospital Review - Healthcare News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive

Most Recent

  • Decoding name displays in health care: Privacy, identification, and compliance unveiled
  • Native American women face heart risks while pregnant, group says
  • Picking the ‘right’ sunscreen isn’t as important as avoiding these 6 mistakes
  • Empowering Black nurses for lasting change [PODCAST]
  • Master time management with 7 productivity strategies for optimal results

Copyright

© 2023 Payer+Provider's Health System Review.

  • Return to top
Published by Payer+Provider Syndicate.